EFFECTS OF FR50948, A NEW ORALLY ACTIVE ANTIALLERGIC AGENT, IN EXPERIMENTAL ALLERGIC MODELS

被引：5
|
作者：
HIROI, J
OHARA, K
KOBAYASHI, K
FUJITSU, T
FUJII, T
MOTOYAMA, Y
MORI, J
SHIBAYAMA, F
机构：
来源：
JAPANESE JOURNAL OF PHARMACOLOGY | 1988年 / 46卷 / 04期
关键词：
D O I：
10.1254/jjp.46.337
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：337 / 348
页数：12
相关论文
共 50 条
  • [31] PROPHYLACTIC TREATMENT OF BRONCHIAL-ASTHMA IN CHILDREN WITH A NEW, ORALLY ACTIVE AGENT, KETOTIFEN
    WEHEBA, AS
    PHARMATHERAPEUTICA, 1979, 2 (03) : 147 - 152
  • [32] THE PHARMACOLOGIC PROFILE OF WY-41,195, A NEW ORALLY EFFECTIVE ANTI-ALLERGIC AGENT
    CARLSON, RP
    DERVINIS, A
    DILUIGI, JM
    CAPETOLA, RJ
    ROSENTHALE, ME
    LEWIS, AJ
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1982, 32-2 (12): : 1546 - 1553
  • [33] Variable effects of cyclophosphamide in rodent models of experimental allergic encephalomyelitis
    Mangano, K.
    Nicoletti, A.
    Patti, F.
    Donia, M.
    Malaguarnera, L.
    Signorelli, S.
    Magro, G.
    Muzio, V.
    Greco, B.
    Zaratin, P.
    Meroni, P.
    Zappia, M.
    Nicoletti, F.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2010, 159 (02): : 159 - 168
  • [34] Effects of the novel orally active antiestrogen TZE-5323 on experimental endometriosis
    Saito, T
    Yoshizawa, M
    Yamauchi, Y
    Kinoshita, S
    Fujii, T
    Mieda, M
    Sone, H
    Yamamoto, Y
    Koizumi, N
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2003, 53 (07): : 507 - 514
  • [35] COMPARATIVE INVITRO ACTIVITY AND BETA-LACTAMASE STABILITY OF FR-17027, A NEW ORALLY ACTIVE CEPHALOSPORIN
    NEU, HC
    CHIN, NX
    LABTHAVIKUL, P
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (02) : 174 - 180
  • [36] PREVENTION AND SUPPRESSION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS BY AN ORALLY-ACTIVE LEUKOCYTE RECRUITMENT INHIBITOR, NPC-16570
    LOWE, VC
    NORONHABLOB, L
    AGENTS AND ACTIONS, 1993, 39 : C83 - C85
  • [37] Effects of KW-4679 a new orally active antiallergic drug, on antigen-induced bronchial hyperresponsiveness, airway inflammation and immediate and late asthmatic responses in guinea pigs
    Ohmori, K
    Ishii, H
    Sasaki, Y
    Ikemura, T
    Manabe, H
    Kitamura, S
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1996, 110 (01) : 64 - 72
  • [38] INHIBITORY EFFECT OF HSR-6071, A NEW ANTIALLERGIC AGENT, ON EXPERIMENTAL ASTHMA IN RATS AND GUINEA-PIGS
    MAKINO, E
    OHASHI, T
    TAKAHASHI, H
    KATO, H
    ITO, Y
    NAGAI, H
    KODA, A
    AZUMA, H
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1990, 42 (04) : 236 - 241
  • [39] Effects of olopatadine, a new antiallergic agent, on human liver microsomal cytochrome P450 activities
    Kajita, J
    Inano, K
    Fuse, E
    Kuwabara, T
    Kobayashi, H
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (12) : 1504 - 1511
  • [40] PREVENTION OF ANTIGEN-INDUCED BRONCHOCONSTRICTION BY IODOXAMIDE ETHYL, A NEW ORALLY ACTIVE ANTI-ALLERGIC DRUG
    KATCHER, ML
    REED, CE
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1980, 66 (03) : 223 - 226
12345